Levothyroxine Sodium
Product Images NDC 68788-9159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68788-9159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levothyroxine Sodium Tablets Usp 1)

Chemical Structure (Levothyroxine Sodium Tablets Usp 1)
Not available.*
FDA Label Image

Levothyroxine Sodium Tablets, Ups 200mcg (0.2mg) (Levothyroxine Sodium Tablets Usp 12)

Levothyroxine Sodium Tablets, Ups 200mcg (0.2mg) (Levothyroxine Sodium Tablets Usp 12)
This text appears to be a warning label for Levothyroxine Sodium Tablets, cautioning against the transfer of the medication to anyone other than the patient for whom it was prescribed. It provides details such as the dosage strength (200mcg or 0.2mg), lot number, packaging date, and expiration date. The manufacturer of the medication is Lannett Co. Inc. based in Philadelphia. There is also mention of Synthroid, a similar medication. The text does not provide any further information beyond this and is not readable in some parts, likely due to scanning errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.